| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/17/2011 | US20110038849 Inhibitory polynucleotide compositions and methods for treating cancer |
| 02/17/2011 | US20110038834 Novel avian cytokines and genetic sequences encoding same |
| 02/17/2011 | US20110038790 Treatment and prophylaxis of amyloidosis |
| 02/17/2011 | CA2771105A1 Compositions and methods for the therapy and diagnosis of influenza |
| 02/17/2011 | CA2770771A1 Monoclonal antibodies for pbp2-a protein and homologous sequences for treatment of infections and immunodiagnosis on bacteria from phylum firmicutes |
| 02/17/2011 | CA2770737A1 Antibodies against human respiratory syncytial virus (rsv) and methods of use |
| 02/17/2011 | CA2769822A1 Methods of modulating immune function |
| 02/17/2011 | CA2769674A1 Combination therapy of an afucosylated cd20 antibody with bendamustine |
| 02/17/2011 | CA2769595A1 Combination therapy of an afucosylated cd20 antibody with fludarabine and/or mitoxantrone |
| 02/17/2011 | CA2769394A1 Human monoclonal antibody against s. aureus derived alpha-toxin and its use in treating or preventing abscess formation |
| 02/16/2011 | EP2284260A1 Anti-(influenza a virus subtype h5 hemagglutinin) monoclonal antibody |
| 02/16/2011 | EP2284194A1 Antibodies directed to angiopoietin-2 and uses thereof |
| 02/16/2011 | EP2284193A1 Human monoclonal antibody against S. aureus derived apha-toxin and its use in treating or preventing abscess formation |
| 02/16/2011 | EP2284192A2 Camelidae antibodies for sublingual administration |
| 02/16/2011 | EP2284189A2 Nucleic acid molecules encoding fibroblast growth factor-like (FGF-like) polypeptides |
| 02/16/2011 | EP2283869A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in the treatment of viral infections and cancer |
| 02/16/2011 | EP2283868A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in the treatment of viral infections and cancer |
| 02/16/2011 | EP2283862A1 Antitumor agent |
| 02/16/2011 | EP2283861A2 Method for Treating Thrombocytopenia with Monoclonal IVIG |
| 02/16/2011 | EP2283860A2 Use for interleukin-33 (il-33) and the il-33 receptor complex |
| 02/16/2011 | EP2283859A2 Pantropic canine coronavirus |
| 02/16/2011 | EP2283855A2 Polypeptides et polynucleotides de phorphorymonas gingivalis |
| 02/16/2011 | EP2283854A2 Porphorymonas gingivalis polypeptides and polynucleotides |
| 02/16/2011 | EP2283853A2 Porphorymonas gingivalis polypeptides and polynucleotides |
| 02/16/2011 | EP2283852A2 Porphorymonas gingivalis polypeptides and polynucleotides |
| 02/16/2011 | EP2283831A2 Biomakers for pre-selection of patients for anti-IGF1R therapy |
| 02/16/2011 | EP2283358A2 Immunomodulating compositions and methods of use thereof |
| 02/16/2011 | EP2283042A2 Isolated monoclonal antibody or fragment thereof binding prostate specific membrane antigen, conjugates and uses thereof |
| 02/16/2011 | EP2283041A1 Humanized anti-factor d antibodies and uses thereof |
| 02/16/2011 | EP2283040A2 Methods and compositions based on alk1 antagonists for modulating angiogenesis and pericyte coverage |
| 02/16/2011 | EP2283039A1 Methods of converting fab sequences into single chain antibody sequences |
| 02/16/2011 | EP2283035A2 Leishmania vaccine using sand fly salivary immunogen |
| 02/16/2011 | EP2283031A2 Lyme disease vaccine |
| 02/16/2011 | EP2282773A2 Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylation |
| 02/16/2011 | EP2282772A1 Compositions and methods to enhance the immune system. |
| 02/16/2011 | EP2282770A2 Antibodies with altered binding to fcrn and methods of using same |
| 02/16/2011 | EP2282769A2 Dual variable domain immunoglobulins and uses thereof |
| 02/16/2011 | EP2282768A1 Anti-hmga1 monoclonal antibodies, process for their preparation and their use for the quantitative determination of hmga1 |
| 02/16/2011 | EP2282760A1 Method for the treatment or prophylaxis of chronic inflammatory diseases |
| 02/16/2011 | EP2282758A2 Antibodies and vaccines for use in therapeutic and diagnostic methods for alpha-synuclein-related disorders |
| 02/16/2011 | EP2282757A1 Neutralization of gm-csf for the treatment of heart failure |
| 02/16/2011 | EP2282720A2 Intracellular antibody delivery |
| 02/16/2011 | EP1545609B1 Antibodies directed against oxidised apolipoprotein B |
| 02/16/2011 | EP1360288B1 Focused libraries of genetic packages |
| 02/16/2011 | EP1222854B1 Prevention and treatment of diseases associated with blood coagulation |
| 02/16/2011 | EP1222265B1 Novel nicotinic acetylcholine receptor subunit, its isolation and use |
| 02/16/2011 | CN1798767B Alteration of fcrn binding affinities or serum half-lives of antibodies by mutagenesis |
| 02/16/2011 | CN101978054A Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 02/16/2011 | CN101977937A Ron antibodies and uses thereof |
| 02/16/2011 | CN101977936A Antagonist antibodies of protease activated receptor-1 (par1) |
| 02/16/2011 | CN101977935A Methods and compositions for treating and monitoring treatment of il-13-associated disorders |
| 02/16/2011 | CN101977934A Methods and compositions for targeting polyubiquitin |
| 02/16/2011 | CN101977933A Biomarkers |
| 02/16/2011 | CN101977932A Engineered antibody constant domain molecules |
| 02/16/2011 | CN101977927A Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto |
| 02/16/2011 | CN101977627A Combinations and methods for subcutaneous administration of immune globulin and hyaluronidase |
| 02/16/2011 | CN101975857A Virus disaggregating agent and method for disaggregating virus antigen-antibody complex and detecting HCV (Hepatitis C Virus) antigen |
| 02/16/2011 | CN101975856A Preparation method of fluorescence antibody for detecting Newcastle disease virus and solid-phase immunofluorescence detection assay kit |
| 02/16/2011 | CN101974535A Preparation and application of novel anti-ErbB2 humanized antibody MIL12 |
| 02/16/2011 | CN101974088A Breast globin monoclonal antibody and application thereof in breast cancer diagnosis |
| 02/16/2011 | CN101974087A Anti-fibronectin fragment monoclonal antibody |
| 02/16/2011 | CN101974086A Preparation method and applications of anti-latent membrane protein LMP2A monoclonal antibody |
| 02/16/2011 | CN101974083A Humanized HIRRP (HSV-1 Infection Related Repress) protein molecule for resisting HSV1 virus infection |
| 02/16/2011 | CN101974072A Escherichia coli TolC antigen as well as antibody and application thereof |
| 02/16/2011 | CN101972479A Preparation process of intravenous injection human immunoglobulin |
| 02/16/2011 | CN101972478A 抗体治疗 Antibody therapy |
| 02/16/2011 | CN101343323B Anti-interleukins-8 antibody |
| 02/15/2011 | US7888486 Antagonist antibodies against GDF-8 |
| 02/15/2011 | US7888485 Anti-pleiotrophin antibodies and methods of use thereof |
| 02/15/2011 | US7888484 Humanized antibodies to interferon alpha receptor-1 (IFNAR-1) |
| 02/15/2011 | US7888483 Antagonists of protease activated receptor-1 (PAR1) |
| 02/15/2011 | US7888482 Antibodies that bind PAR-2 |
| 02/15/2011 | US7888481 Anti-interferon alpha monoclonal antibodies and methods for use |
| 02/15/2011 | US7888480 Tyrosine phosphorylated leukemia-related signaling protein specific immunoglobulin for use as evaluative tools in diagnosing/predicting cell proliferative disorders; protein phosphorylation and cancer detection |
| 02/15/2011 | US7888479 Humanized antibodies against monocyte chemotactric proteins |
| 02/15/2011 | US7888478 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 02/15/2011 | US7888477 Isolated polynucleotide of ovarian tumor polypeptides, immunogenic portions, polynucleotides that encode polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides |
| 02/15/2011 | US7888473 Non-functional P2X7 receptor |
| 02/15/2011 | US7888372 Compositions and methods for modulating bone mineral deposition |
| 02/15/2011 | US7888092 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon |
| 02/15/2011 | US7888071 DNA encoding IL-2 fusion proteins with modulated selectivity |
| 02/15/2011 | US7888066 Diagnosing nervous system disorders; obtain tissue sample, measure expression of semaphorin 3 and downstream effectors , amplified concentrations of semaphorins indicate nervous system disorders; drug screening |
| 02/15/2011 | US7888052 detecting a Cripto polypeptide; for in vitro diagnostics/antitumor agents; gene overexpression of cell surface proteins; bind Cripto and block the interaction between Cripto and activin-like kinase (ALK) 4 |
| 02/15/2011 | US7888050 Method for quantifying phosphokinase activity on proteins |
| 02/15/2011 | US7888039 uses the heat shock protein 60 (Hsp60) of Spiroplasma mirum; rapid detection, noninvasive ; Spiroplasma infection |
| 02/15/2011 | US7887814 binding proteins, fused with transferrins; for treatment of Alzheimer's, Down Syndrome, infant encephalitis, AIDS, and autoimmune diseases |
| 02/15/2011 | US7887810 Clostridial toxin derivatives able to modify peripheral sensory afferent functions |
| 02/15/2011 | US7887809 Neovascular-targeted immunoconjugates |
| 02/15/2011 | US7887807 Anti-IL-12 antibodies and compositions |
| 02/15/2011 | US7887806 Mammalian receptor proteins DCRS5; method of treatment |
| 02/15/2011 | US7887804 Methods for treating disease-states associated with RG1 using immunoconjugates |
| 02/15/2011 | US7887803 antibody, or binding fragment thereof, that binds selectively to an epitope presented by misfolded form of superoxide dismutase 1; use in diagnosis, prognosis and therapeutic intervention in neurodegenerative Alzheimer's disease, Parkinson's disease, Huntington's disease |
| 02/15/2011 | US7887802 immunohistochemistry; skin thickening caused by ultraviolet treated by using the antibody; inhibit production of IFN-.gamma; promoting keratinocyte differentiation induction and suppressing epidermal thickening, skin cancer; inhibiting growth of keratinocytes; promotes hair growth; hyperplasia |
| 02/15/2011 | US7887800 activating endothelial growth factors VEGF-C or vascular endothelial growth factor D (VEGF-D) with plasmin; Angiogenesis |
| 02/15/2011 | US7887799 Antibodies to fibroblast growth factor-like polypeptides |
| 02/15/2011 | US7887798 Methods of treating cancer by administering antibodies to CD200 |
| 02/15/2011 | US7887796 for a disorder of a subject's heart involving loss of cardiomyocytes by administering an amount of an agent effective to cause cardiomyocyte proliferation within the subject's heart; Vitamin D3 Up-Regulated Protein-1 |
| 02/15/2011 | CA2396342C Sandwich immunoassay and monoclonal antibodies for comp, cartillage oligomeric matrix protein |
| 02/15/2011 | CA2383424C Novel b7-4 molecules and uses therefor |
| 02/15/2011 | CA2352765C Hapten-carrier conjugates for treating and preventing nicotine addiction |